Alvogen

Alvogen

Setting a new standard for the future of Pharma.

Founded 2009

United States 512 employees Private Equity Total: $100.00M Health Care, Manufacturing +1

Alvogen is a global pharmaceutical company that was founded in 2009 and is headquartered in the United States. The company is focused on developing, manufacturing, and selling generic, brand, over-the-counter brands (OTC), and biosimilar products for patients worldwide. With the slogan "Setting a new standard for the future of Pharma," Alvogen aims to improve the accessibility of high-quality medicines globally. Alvogen has commercial operations in 35 countries and employs 2,800 individuals. It operates four manufacturing and development hubs in the U.S., Romania, Korea, and Taiwan. Notably, North America serves as Alvogen’s single largest market, with key markets also including South Korea, Russia, Taiwan, Romania, Hungary, Ukraine, Japan, and China. In its most recent funding round, Alvogen secured a significant $100.00M investment in a Private Equity Round on 30 June 2021, with the notable investor being Aztiq Pharma Partners. This latest investment underscores the confidence that investors have in Alvogen’s potential for growth and impact in the pharmaceutical industry. With a strong global presence and a focus on improving access to high-quality medicines, Alvogen is well-positioned for continued success in the future.

Funding Stage	Amount	Investors	Lead Investors	Date
Private Equity Round	$100.00M	1	Aztiq Pharma Partners	30 Jun 2021
Private Equity Round	Undisclosed	-		19 Nov 2010
Venture Round	Undisclosed	-		01 Jan 2009

Funding Stage

Amount

Investors

Lead Investors

Date

Private Equity Round

$100.00M

Aztiq Pharma Partners

30 Jun 2021

Private Equity Round

Undisclosed

19 Nov 2010

Venture Round

Undisclosed

01 Jan 2009

FAQ About Alvogen

Setting a new standard for the future of Pharma.

Alvogen was founded in 2009.

Alvogen is headquartered in United States.

Alvogen operates in Health Care, Manufacturing and Pharmaceutical. Its work centres on Pharmaceuticals, Generic Medicines, Brand Medicines and Biosimilars.

Alvogen has approximately 512 employees.

Alvogen has completed 3 funding rounds, raising a total of $100.00M. The latest funding stage is Private Equity.

Top alternatives and competitors to Alvogen include Lotus Pharmaceutical Co., Ltd, Aspen Pharma Group, Lyrus, ciclum farma, unipessoal, MODAVAR PHARMACEUTICALS LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Alvogen and Lotus Pharmaceutical Co., Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Alvogen

Funding Rounds & Investors (3)

Alvogen Alternatives & Competitors

FAQ About Alvogen